ENZY — Enzymatica AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK849.57m
- SEK776.56m
- SEK45.58m
Annual income statement for Enzymatica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 111 | 57.2 | 48.9 | 50.9 | 45.6 |
| Cost of Revenue | |||||
| Gross Profit | 76 | 33.4 | 28.5 | 31.9 | 30.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 123 | 102 | 117 | 99 | 97.6 |
| Operating Profit | -12.1 | -45.2 | -68.2 | -48.1 | -52.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.1 | -45.7 | -68.7 | -49.7 | -53.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.2 | -45.4 | -68.7 | -49.7 | -53.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.2 | -45.4 | -68.7 | -49.7 | -53.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.2 | -45.4 | -68.7 | -49.7 | -53.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.086 | -0.286 | -0.411 | -0.28 | -0.28 |
| Dividends per Share |